Zimmer Biomet Holdings ZBH · USD
Health Care · Health Care Equipment & Supplies · US listing · 🇺🇸 United States
S&P 500
101.47
-1.79%
Close of 19 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
Price performance
Chart by TradingView, with its own licensed prices
- Market value
- $19.63bn
- Last close × shares
- Volume
- 1.8m
- Shares, 19 Nov 2026
- Price to earnings
- 31.0
- Dividend yield
- 0.87%
About Zimmer Biomet Holdings
From its filings with the US Securities and Exchange Commission
Zimmer Biomet Holdings is based in Warsaw, Indiana and is incorporated in Delaware. Its shares trade on NYSE under the ticker ZBH. It is a member of the S&P 500. The SEC classifies its business as orthopedic, prosthetic & surgical appliances & supplies. In the fiscal year to 31 December 2025, it reported revenue of $8.23bn and net income of $705.1m. At that date it held total assets of $23.09bn and shareholders' equity of $12.70bn. By business, Knees. brought in 40.4% of revenue, followed by SET. at 26.1% and Hips. at 25.4%. By region, United States [Member] accounted for 57.9%, followed by Non-US [Member] at 42.1%.
Zimmer Biomet Holdings was incorporated in Delaware in 2001. Our history dates to 1927, when Zimmer Manufacturing Company, a predecessor, was founded in Warsaw, Indiana. On August 6, 2001, we were spun off from our former parent and became an independent public company. In 2015, we acquired LVB Acquisition, Inc. (“LVB”), the parent company of Biomet, Inc. (“Biomet”), and LVB and Biomet became our wholly-owned subsidiaries. In connection with the merger, we changed our name from Zimmer Holdings, Inc. to Zimmer Biomet Holdings, Inc.
Our primary customers include orthopedic surgeons, neurosurgeons, and other specialists, healthcare institutions, stocking distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. These customers range from large multinational enterprises to independent clinicians.
We market and sell products through two principal channels: 1) direct to healthcare institutions, such as hospitals and ambulatory surgery centers, referred to as direct channel accounts; and 2) through stocking distributors and healthcare dealers. With direct channel accounts and some healthcare dealers, inventory is generally consigned to sales agents or customers. With sales to stocking distributors, some healthcare dealers and some hospitals, and at times to some direct channel accounts, title to product typically passes upon shipment. Consignment sales represented approximately 85 percent of our net sales in 2025. No individual customer accounted for more than 2 percent of our net sales for 2025.
Quoted from its 10-K, filed 20 Feb 2026. Read the filing on SEC.gov ↗
How it makes its money
Revenue, year to 31 Dec 2025
- Knees. $3.32bn · 40.4%
- SET. $2.15bn · 26.1%
- Hips. $2.09bn · 25.4%
- Technology And Data, Bone Cement and Surgical [Member] $665.6m · 8.1%
Latest on Zimmer Biomet Holdings
Our reporting
- Zimmer Biomet Holdings falls 2.71% in Thursday's session
- Zimmer Biomet Holdings rises 2.63% in Monday's session
- Zimmer Biomet Holdings rises 13.50% in Wednesday's session
- Zimmer Biomet Holdings rises 2.99% in Monday's session
- Zimmer Biomet Holdings falls 2.99% in Friday's session
- Zimmer Biomet Holdings rises 3.88% in Thursday's session
Next results
Due on 9 Feb 2027. Analysts expect earnings of 2.49 a share.
Other Health Care listings
Scenario calculator
Try your own numbers. This is arithmetic, not a forecast.
Gain or loss
Return
Leaves out fees, taxes and financing.
Frequently asked questions
What is Zimmer Biomet Holdings's ticker?
Zimmer Biomet Holdings trades as ZBH on its US listing, under ISIN US98956P1021.
What was Zimmer Biomet Holdings's last closing price?
101.47 on 19 Nov 2026. The figure is in USD and is never converted.
When does Zimmer Biomet Holdings next report results?
Results are expected on 9 Feb 2027, according to our data supplier.
Sources and methodology
- Chart
- TradingView
- Close and company data
- SEC filings and our data supplier
- News
- Our reporting
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.